Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1185.1000 -6.20 (-0.52%)
NSE Jul 07, 2025 15:31 PM
Volume: 697.3K
 

1185.10
-0.52%
Angel Broking
Aurobindo Pharmaceuticals (APL) has a big relief in form of Establishment Inspection report (EIR) for Unit-4 facility in which the USFDA has closed issued Form 483. The Form 483 is issued to a firms management at the conclusion of an inspection when an investigator(s) has observed any conditions that may constitute violations of the Food
Number of FII/FPI investors decreased from 730 to 724 in Mar 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended